(Finance) – “We are very satisfied with the quotation and the response we’ve had from investors has been really strong, with demand 1.44 times our supply. So we are really proud of this achievement and we have to work even harder to do to reciprocate the trust that investors have given us”. He told Finance Aniello Aliberti, president and CEO Of International Medical Devices (IMD), on the sidelines of the listing ceremony on Euronext Growth Milan (EGM), the Borsa Italiana market dedicated to SMEs with high growth potential.
The group – which ended 2022 with revenues of 41.8 million, an EBITDA margin of 13.5% and a net profit of 3.2 million – operates in the medtech sector, particularly in the research and development, production and distribution of a wide range of diagnostic systems for X-Ray. Through the three operating companies (Technix, IMD Generators and Intermedical), has been active for over 40 years in the medical field, offering highly innovative and cutting-edge solutions in terms of diagnostic imaging.
“The main focus post-IPO, as we have already told investors, is get bigger – explained Aliberti – So we will definitely be making acquisitionsto have new companies in our group so that we can cover a wider product portfolio than we have now.”
IMD represents the thirteenth admission since the beginning of the year on EGM, bringing the number of companies currently listed on this market to 194. In the placement phase, it raised 5.42 million euros, with a free float of 15% and a market capitalization at the IPO price of 36.2 million euros.
Aliberti stated that “the prospects for 2024 they definitely are very interesting. From what we’re already seeing this year, there will be some new equipment that we put on the market, very high-tech equipment and that several dealers and our customers are already asking us for. So I’m very confident for 2024.”